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1. Introduction 
The stabilities of the cis- and trans- forms of the 
X-Pro peptide group differ only slightly by -2.0 to 2.0 
kcal/mol-’ for linear polypeptides [ 11. In small cyclic 
peptides, the ring closure enforces the formation of 
cis-peptide groups [2,3]. It is surprising, therefore, 
that there are only few reports of X-Pro cis-peptide 
groups found in globular protein molecules. Further- 
more, most of these are questioned by the authors 
due to the uncertainty in the interpretation of a 
Fourier map calculated with phases obtained from 
isomorphous replacement [4,5a,Sb,6-81. During the 
course of the constrained crystallographic refinement 
of the crystal structure of the Bence-Jones Protein Rei 
[9a,9b] we found evidence for two X-Pro cis-peptide 
groups and were able to confirm this by difference 
Fourier methods. 
2. Crystallographic refinement 
The constrained crystallographic refinement used 
had already been applied to the crystal structures of 
PTI [lOa,lOb] andPT’-trypsin complex [lla,llb]. 
It has been shown that those protein structures had 
been refined to a final accuracy of better than 0.1 A 
and 0.2 A respectively using this procedure. 
The refinement procedure consists of cycles of 
phase calculation, Fourier-synthesis and real space 
refinement [ 121. Difference Fourier-syntheses are 
The nomenclature recommended by IUPAC-IUB [ 141 is used 
in this paper. 
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inserted and analysed to detect gross errors of the 
model which the automated procedure cannot 
correct. A refinement was performed with the Rei 
crystal structure using intensity data to 2.2 A resolu- 
tion [9b]. After several rounds of refinement cycles 
and difference maps, we found large density residuals 
at the Ser 7.Pro 8 and Leu 94-Pro 95 segments which 
had been built in the trans-conformation. The local 
distribution of maxima and minima around these two 
peptide groups was very similar and consistent in the 
two independent molecules present in the asymmetric 
unit. Fig. 1 a shows 6 consecutive sections through 
the difference Fourier map, calculated with a Ser 7- 
Pro 8 trans-peptide group. There is a large negative 
density at the positions of the Ser 7 carbonyl carbon 
and oxygen atoms and there is high positive density 
unaccounted for at sections 5 and 6. This clearly 
suggested the presence of a cis-peptide group, which 
would have its carbonyl group approximately in the 
position of Cp of Ser 7 in the trans-peptide. Co-07 
of Ser 7 would occupy the residual positive density. 
A model was then constructed with Ser 7-Pro 8 and 
Leu 94-Pro 95 cis-peptide groups and refined as describ- 
ed above. 
The finally calculated difference Fourier map is 
shown in fig. lb. It is practically featureless. The 
positive density visible in the lower right hand corner 
of sections 5 and 6 is due to the side-chain of Gln 24, 
which is misplaced. The refinement has progressed to 
a crystallographic R-value of 0.26. 
R= CllFel-IF&t 
ClF,,l ’ 
summation over alI 13 000 reflections. Fe -observed 
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(a) 
Table 1 
Main chain torsion angles in the two c&Pro-bends in VRei 
0 degrees J, 
Gin 6 
Ser 7 
Pro 8 
Ser 9 
Ser 93 
Leu 94 
Pro 95 
Tyr 96 
-106 138 
-145 139 
- 62 174 
- 95 -18 
-137 155 
- 82 150 
- 73 156 
- 71 125 
(b) 
Fig. 1. a) Difference Fourier map at the segment around Pro 
8 calculated with a Ser-Pro trans-peptide group. Contour 
levels at + 0.05 e/A’, starting at f 0.1 e/A3. Negative contour 
levels dashed. 70X is Oy, which has been excluded from the 
calculations. b) Difference Fourier map at the segment around 
Pro 8 calculated with a Ser-Pro cis-peptide group. Contour 
levels as above. 
The angles are averages over the two molecules in the asym- 
metric unit of the crystal cell. 
structure factor amplitude, F,-calculated structure 
factor amplitude. The difference map shows a few 
regions where the model is still in error, but these are 
far from the two proline residues discussed and further 
refinement will not influence these segments. 
Table 1 shows the main chain torsion angles of the 
residues around Pro 8 and Pro 95, averaged over the 
two independent molecules. The two independent 
chains are very similar, the average deviation being 
8” in torsion angles. Fig. 2 is a stereo-plot of the 
electron density and its model interpretation in the 
vicinity of Pro 8 showing a very satisfactory fit. 
Fig. 2. Electron density map and corresponding model interpretation at Pro 8. Contour levels in steps of 0.2 e/As, starting from 
0.2 e/A3. Ser 7 is at the lower right hand side. Its @-Or lies below the Ser-Pro peptide group. 
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3. Discussion 
The demonstration of two cis-prolines leads to a 
general consideration of the underlying structural 
principles. Both residues 8 and 95 lie in the third posi- 
tion of reverse turns which may be characterized as 
open turns according to the definitions suggested in 
ref. [ 131. The CY-CY (first and fourth residue in the 
turn) distances are less than 6.0 A, but there is no 
hydrogen bond between Or and Nq. 
In trying to build a reverse turn using conventional 
model parts with proline at the third position, unallow- 
ed close contacts between Cg and Ct of proline are 
observed. Overcrowding between C$ and Ce or Nz 
occurs over a considerable range of the tiZ torsion 
angle. A glycine in the second position should of course 
make a trans-proline possible. Building the reverse turn 
with a X-Pro cis-peptide group, Cf is removed far from 
C$ of the proline residue (see fig. 2). An inspection 
of stereo-drawings and atomic coordinates of other 
globular protein molecules, where cis-prolines have 
been reported, showed that in all of these cases the 
proline residues are at the third position of a reverse 
open turn: ribonuclease (Pro 93 and 114) [7], 
thermolysin (Pro 5 1) [4] , sustilisin (Pro 168) [5a, 
Sb] , erythrocruorin (Pro EF3,74) [6], and carbonic 
anhydrase (Pro 29 and 200) [8]. 
There appears to be a considerable variation in the 
main chain conformational angles of these various 
Cis-Pro-bends (table 1). None of these (except per- 
haps in subtilisin) shows Or -Nq hydrogen-bonding. 
There is no indication of a certain aminoacid sequence 
preferring this conformation, possibly due to the small 
number of observations available as yet. The observa- 
tion of 9 cis-Pro-bends in 6 different protein molecules 
suggests that this is an important structural element. 
In view of the uncertainty of protein models ob- 
tained from Fourier maps calculated with isomor- 
phous phases, a reexamination of segments around 
proline residues in other protein structures might be 
advisable. 
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